Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLMB | 22.97 | 0.03 | +0.14% |
| Franklin Municipal Green Bond ETF | |||
| ERC | 8.85 | -0.02 | -0.23% |
| Allspring Multi-Sector Income Fund | |||
| PSFJ | 27.43 | -0.36 | -1.29% |
| Pacer Swan SOS Flex (July) ETF | |||
| FNDB | 21.34 | -0.36 | -1.66% |
| Schwab Fundamental U.S. Broad Market ETF | |||
| ESGV | 92.11 | -2.28 | -2.42% |
| Vanguard ESG US Stock ETF | |||
A.I.dvisor indicates that over the last year, CYYNF has been loosely correlated with CADL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYYNF jumps, then CADL could also see price increases.
| Ticker / NAME | Correlation To CYYNF | 1D Price Change % | ||
|---|---|---|---|---|
| CYYNF | 100% | N/A | ||
| CADL - CYYNF | 46% Loosely correlated | -4.26% | ||
| URGN - CYYNF | 38% Loosely correlated | +1.42% | ||
| MLLCF - CYYNF | 31% Poorly correlated | N/A | ||
| INKT - CYYNF | 27% Poorly correlated | +2.49% | ||
| BRTX - CYYNF | 26% Poorly correlated | N/A | ||
More | ||||